Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.65618 | 73 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.09301 | 76 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.90871 | 75 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.31799 | 77 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.8243 | 74 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.83682 | 75 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.10295 | 77 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.74629 | 73 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.86623 | 74 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.92473 | 74 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.64205 | 73 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.58697 | 72 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.7306 | 73 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.59378 | 72 |